Summary
In order to establish the clinical validity of currently used ways of subtyping panic disorder the predictive power of associated current avoidance behaviour and (secondary) major depression for the response to active treatment (alprazolam, imipramine) was tested. The analysis was based on the data from the Cross-National-Collaborative-Panic-Study. Limited support for validity evidenced by predicting drug response was found for grading panic disorder by the severity of avoidance behaviour: patients with panic attacks and agoraphobia are more responsive to imipramine (compared with alprazolam) when using the reduction of the total number of panic attacks (or of spontaneous panic attacks) as the outcome criterion; patients without any avoidance behaviour did better with alprazolam (compared with imipramine).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association (1987) Diagnostic Criteria from DSM-III-R. Washington, D.C.
American Psychiatric Association (1988) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington, D.C.
Argyle N (1990) A comparison of various categorical and dimensional descriptions of depression as an influence on outcome in the treatment of panic disorder.
Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes R, Pecknold JC, Rifkin A, Swinson RP (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. Arch Gen Psychiatry 45:413–422
Cloninger CR, Martin RL, Clayton P, Guze SB (1981): A blind floow-up and family study of anxiety neurosis. Preliminary analysis of the St. Louis 500. In: Klein DE, Rabkin JG (eds) Anxiety: new research and changing concepts. Raven Press, New York, pp 137–154
Cross-National Collaborative Panic Study, Second Phase Investigators (1991) Drug treatment of panic disorder: comparative efficacy of alprazolam, imipramine and placebo. Br J Psychiatry (in press)
Freund RJ, Littell RC, Spector PC (1986) SAS system for linear models. Cary, N.C.
Kendell RE (1989) Clinical validity. Psychol Med 19:45–55
Klein DF (1964) Delineation of two drug responsive syndromes. Psychopharmacologia 5:397–408
Klein DF (1981) Anxiety reconceptualized. In: Klein DF, Rabkin JG (eds) Anxiety, new research and changing concepts. Raven Press, New York, pp 235–265
Klein DF (1987) Anxiety reconceptualized. Gleaning from pharmacological dissection — early experience with imipramine and anxiety. In: Klein DF (ed) Anxiety. Karger, Basel, pp 235–263
Klein DF, Klein HM (1989) The utility of the panic disorder concept. Eur Arch Psychiatry Neurol Sci 238:268–279
Klerman GL (1988) Anxiety and depression. In: Burrows G, Davies B (eds) Handbook of studies on anxiety. Elsevier, New York, pp 145–164
Klerman GL (1988) Overview of the Cross-National Collaborative Panic Study. Arch Gen Psychiatry 45:407–412
Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL (1988) Secondary depression in panic disorder and agoraphobia. Arch Gen Psychiatry 45:437–443
Lord FM (1963) Elementary models for measuring change. In: Harris CW (ed) Problems in measuring change. The University of Wisconsin Press, Madison, pp 21–38
Maier W, Buller R (1989) One year follow-up of panic disorder. Outcome and predictions of course. Eur Arch Psychiatry Neurol Sci 238:105–109
Maier W, Buller R, Sonntag A, Heuser I (1986) Subtypes of panic attacks and ICD-9 classification. Eur Arch Psychiatry Neurol Sci 235:361–366
Maier W, Phillipp M, Buller R (1988) The value structured clinical interview. Arch Gen Psychiatry 45:963–964
Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O (1989) Avoidance behaviour and major depression in panic disorder: a report from the Cross National Collaborative Panic Study. Psychiatr Dev 2:123–142
Marks IM (1987) Fears, phobias, and rituals. Oxford University Press, New York
Marks IM, Matthews AM (1979) Brief standard self-rating for phobic patients. Behav Res Ther 17:263–267
Noyes R, Clancy J, Hoenk PR, Slymen OJ (1980) The prognosis of anxiety neurosis. Arch Gen Psychiatry 31:173–177
Noyes R, Crowe RR, Harris EL, Hamra BJ, McChesney CM, Chaudhry DR (1986) Relationship between panic disorder and agoraphobia. Arch Gen Psychiatry 43:227–232
Rizley R, Kahn RJ, McNeir DM, Frankentheler LM (1986) A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder. Psychopharmacol Bull 16: 61–63
Roth M, Argyle N (1988) Anxiety, panic and phobic disorders: an overview. J Psychiatr Res 22:33–54
Roth M, Mountjoy CQ, Caetano D (1987) Further investigations into the relationship between depressive disorders and anxiety state. Pharmacopsychiatry 15:135–141
Sheehan DV (1982) Current views on the treatment of panic and phobic disorders. Drug Ther Hosp 7:179–193
Spitzer RL, Williams JBW (1988) Revised diagnostic criteria and a new structured interview for diagnosing anxiety disorders. J Psychiatr Res 22:55–85
Spitzer RL, Endicott J, Robins E (1978) Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35: 773–782
Tyrer P, Shawcross C (1988) Monoamine oxidase inhibitors in anxiety disorders. J Psychiatr Res 22 [Suppl 1]:87–98
World Health Organization (1978) International classification of diseases, 9th revision. WHO, Geneva
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maier, W., Rosenberg, R., Argyle, N. et al. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment. Eur Arch Psychiatry Clin Nuerosci 241, 22–30 (1991). https://doi.org/10.1007/BF02193750
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02193750